Opendata, web and dolomites

PAPA-ARTIS SIGNED

Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PAPA-ARTIS project word cloud

Explore the words cloud of the PAPA-ARTIS project. It provides you a very rough idea of what is the project "PAPA-ARTIS" about.

decrease    localized    supply    staged    proceeds    arteriogenesis    papa    elimination    considering    patient    operations    pay    dramatic    disease    brings    network    est    disability    risky    dismal    allowed    blood    endoleaks    outs    artery    diameter    health    15    savings    dramatically    sudden    paraplegia    untreated    found    occlusion    abdominal    time    remarkable    death    treatment    strategies    ischaemia    significantly    devised    quality    aortic    economic    gt    cures    wheelchair    aneurysms    paraspinous    therapeutic    embolization    left    approx    2500    crawford    incidence    groups    undergo    spinal    chronic    internal    20    dilations    cumulative    trial    arteries    aorta    periods    thoracoabdominal    deliberate    continue    thoracic    occlude    rupture    option    bleeding    collateral    segmental    100m    cord    saved    patients    successful    financial    supplying    minimally    asymptomatic    care    rates    reduce    risk    output    individual    invasive    artis    rate    500k    insurance    unemployment    prognosis    lower    mortality    coil    life    permanent   

Project "PAPA-ARTIS" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAET LEIPZIG 

Organization address
address: RITTERSTRASSE 26
city: LEIPZIG
postcode: 4109
website: www.uni-Ieipzig.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://www.papa-artis.eu/
 Total cost 6˙187˙672 €
 EC max contribution 5˙913˙922 € (96%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2016-RTD
 Funding Scheme RIA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAET LEIPZIG DE (LEIPZIG) coordinator 2˙535˙455.00
2    ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK FR (PARIS) participant 364˙750.00
3    UNIVERSIDAD DE GRANADA ES (GRANADA) participant 262˙596.00
4    OREBRO LANS LANDSTING SE (OREBRO) participant 229˙575.00
5    ACADEMISCH ZIEKENHUIS MAASTRICHT NL (MAASTRICHT) participant 223˙852.00
6    SKANE LANS LANDSTING SE (KRISTIANSTAD) participant 221˙302.00
7    UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF DE (HAMBURG) participant 216˙565.00
8    UNIVERSITAETSKLINIKUM FREIBURG DE (FREIBURG) participant 216˙563.00
9    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 216˙562.00
10    ASSOCIATION MARIE LANNELONGUE FR (LE PLESSIS ROBINSON) participant 201˙307.00
11    BARTS AND THE LONDON NHS TRUST UK (LONDON) participant 179˙162.00
12    OSPEDALE SAN RAFFAELE SRL IT (MILANO) participant 166˙368.00
13    CHU HOPITAUX DE BORDEAUX FR (TALENCE) participant 159˙820.00
14    WARSZAWSKI UNIWERSYTET MEDYCZNY PL (WARSZAWA) participant 131˙875.00
15    ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA IT (BOLOGNA) participant 127˙156.00
16    SLASKIE CENTRUM CHOROB SERCA W ZABRZU PL (ZABRZE) participant 119˙910.00
17    MODUS RESEARCH AND INNOVATION LIMITED UK (EDINBURGH) participant 104˙006.00
18    SOCIETE EUROPEENNE DE CARDIOLOGIE FR (BIOT SOPHIA ANTIPOLIS) participant 68˙750.00
19    REGION HOVEDSTADEN DK (HILLEROD) participant 60˙687.00
20    BAYLOR COLLEGE OF MEDICINE US (HOUSTON TX) participant 50˙420.00
21    THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP US (PHILADELPHIA) participant 50˙420.00
22    KITE INNOVATION (EUROPE) LIMITED UK (HUDDERSFIELD) participant 6˙816.00
23    Insel Gruppe AG CH (BERN) participant 0.00
24    LIVERPOOL HEART AND CHEST HOSPITAL NHS FOUNDATION TRUST UK (LIVERPOOL) participant 0.00
25    UNIVERSITE DE LILLE FR (LILLE) participant 0.00
26    UNIVERSITE DE LILLE II - DROIT ET SANTE FR (Lille) participant 0.00

Map

 Project objective

Chronic aortic aneurysms are permanent and localized dilations of the aorta that remain asymptomatic for long periods of time but continue to increase in diameter before they eventually rupture. Left untreated, the patients’ prognosis is dismal, since the internal bleeding of the rupture brings about sudden death. Although successful treatment cures the disease, the risky procedures can result in paraplegia from spinal cord ischaemia or even death, particularly for aneurysms extending from the thoracic to the abdominal aorta and thus involving many segmental arteries to the spinal cord, i.e. thoracoabdominal aortic aneurysms of Crawford type II. Although various strategies have achieved a remarkable decrease in the incidence of paraplegia, it is still no less than 10 to 20%. However, it has been found that the deliberate occlusion of the segmental arteries to the paraspinous collateral network finally supplying the spinal cord does not increase rates of permanent paraplegia. A therapeutic option, ‘minimally invasive segmental artery coil embolization’ has been devised which proceeds in a ‘staged’ way to occlude groups of arteries under highly controlled conditions after which time must be allowed for arteriogenesis to build a robust collateral blood supply. PAPA-ARTiS is a phase II trial to demonstrate that a staged treatment approach can reduce paraplegia and mortality dramatically. It can be expected to have both a dramatic impact on the individual patient's quality of life if saved from a wheelchair, and also upon financial systems through savings in; 1) lower costs in EU health care; 2) lower pay-outs in disability insurance (est. at 500k in Year 1), and; 3) loss of economic output from unemployment. Approx. 2500 patients a year in Europe undergo these high risk operations with a cumulative paraplegia rate of over 15%; therefore >100M per year in costs can be avoided and significantly more considering the expected elimination of type II endoleaks.

 Deliverables

List of deliverables.
Ethical guidance document Documents, reports 2020-01-23 12:42:06
Links with existing projects/professional bodies Documents, reports 2020-01-23 12:42:06
PAPA-ARTiS Project Management Handbook Documents, reports 2020-01-23 12:42:06
Communication strategy Documents, reports 2020-01-23 12:42:06
Project Data Management Plan Documents, reports 2020-01-23 12:42:06
Trial registration Other 2020-01-23 12:42:06
Clinical Trial Data Management plan Documents, reports 2020-01-23 12:42:06

Take a look to the deliverables list in detail:  detailed list of PAPA-ARTIS deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 David Petroff, Martin Czerny, Tilo Kölbel, Germano Melissano, Lars Lonn, Josephina Haunschild, Konstantin von Aspern, Petra Neuhaus, Johann Pelz, David Epstein, Nuria Romo-Avilés, Katja Piotrowski, Christian D Etz
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Staged Segmental Artery Coil-Embolization’ (MIS²ACE): Trial protocol for a Randomized Controlled Multicentre Trial.
published pages: , ISSN: 2044-6055, DOI:
BMJ Open Volume 9, Issue 3 2020-01-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PAPA-ARTIS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PAPA-ARTIS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More